查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654421

ELISpot 和 Fluorospot 檢測市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025-2030 年

ELISpot And Fluorospot Assay Market Size, Share & Trends Analysis Report By Product (Prospective, Retrospective), By Application (Oncology, Neurology, Cardiology), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

ELISpot 和 Fluorospot 檢測的市場趨勢

2024 年全球 ELISpot 和 Fluorospot 檢測市場規模估計為 3.118 億美元，預計 2025 年至 2030 年期間的複合年成長率為 6.3%。這種成長歸因於慢性病和感染疾病的增加、藥物研發活動的增加、研究和診斷應用的增加以及臨床前和臨床環境中受監管的生物分析的擴展。 ELISpot 和 Fluorospot 檢測用於評估免疫反應，在了解各種疾病（包括癌症）對免疫系統的影響方面發揮越來越重要的作用。

ELISpot 和 Fluorospot 檢測用於檢測和表徵可作為癌症免疫治療合適介質的自然產生的腫瘤反應性 T 細胞。此外，這些檢測也用於表位圖譜、腫瘤抗原鑑定以及監測疫苗誘導的 T 細胞和 B 細胞反應。此外，肝細胞癌（HCC）和子宮頸癌的發展分別與人類乳突病毒（HPV）和B型肝炎病毒（HBV）的高風險感染密切相關。腫瘤特異性疫苗經常在動物模型和細胞株中進行測試。例如，已經使用 IFN-Y 和 IL-2 ELISPOT 檢測法在小鼠和細胞株中對人類乳突病毒(HPV)疫苗進行了評估。

透過 IFN-Y ELISPOT 檢測發現轉移性子宮頸癌患者中抗原特異性T 細胞反應的產生有助於研究人員開發新的治療策略。研究人員正致力於透過裝載腫瘤 DNA 或腫瘤勻漿的樹突狀細胞誘導腫瘤特異性細胞毒性 T 淋巴細胞 (CTL) 來阻止癌症進展。另一種方法是使用編碼腫瘤抗原的病毒載體（例如腺病毒載體）產生基因疫苗。腫瘤特異性CTL反應可以透過ELISPOT分析來確定。

IFN-Y ELISPOT 檢測也用於評估高劑量 IL-2 治療對轉移性黑色素瘤和腎細胞癌患者的免疫學效果。隨著癌症發生率的增加，ELISpot 和 Fluorospot 檢測在癌症研究中的應用越來越廣泛，預計這也將推動需求的成長。根據美國國家癌症美國的資料，預計每年癌症病例數將增加至2,990萬，癌症相關死亡人數將達1,530萬人。預計癌症患者數量的快速增加將在預測期內推動市場成長。

這些檢測為評估潛在藥物對免疫系統的影響提供了強而有力的工具。 ELISpot 已成為多種疾病疫苗開發的重要工具，包括免疫力缺乏、瘧疾、結核病、癌症和流感。 ELISpot 測試廣泛用於臨床試驗以評估疫苗。根據世界衛生組織 (WHO) 國際臨床實驗室註冊平台 (ICTRP) 的資料，僅在 2022 年全球就進行了 54,952 次臨床測試。臨床測試和藥物發現活動的增加預計將增加對 ELISpot 和 Fluorospot 檢測的需求，從而推動市場成長。

此外，一些市場參與企業正在加強透過 ELISpot 和 Fluorospot 檢測為各種健康狀況開發先進的解決方案，這進一步推動了市場成長。例如，2023 年 11 月，Revvity 宣佈在印度推出採用 FDA核准的ELISPOT 技術的 T-SPOT 測試，用於潛伏性結核病篩檢。此測試使用標準化樣本，不易受到影響測試表現的血液因素的影響，並能使 T 細胞計數正常化。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. ELISpot 和 Fluorospot 檢測市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章 ELISpot 和 Fluorospot 檢測市場：產品業務分析

  • 2024 年及 2030 年產品市場佔有率
  • 產品細分儀表板
  • 2018 年至 2030 年按產品分類的市場規模、預測與趨勢分析
  • 檢測試劑套件
  • 分析設備
  • 互補產品

5. ELISpot 和 Fluorospot 檢測市場：應用業務分析

  • 2024 年和 2030 年應用市場佔有率
  • 應用程式細分儀表板
  • 2018 年至 2030 年按應用分類的市場規模、預測與趨勢分析
  • 研究用途
  • 診斷用途

6. ELISpot 和 Fluorospot 檢測市場-最終用途業務分析

  • 2024 年及 2030 年終端用途市場佔有率
  • 最終用途細分儀表板
  • 2018 年至 2030 年按最終用途分類的市場規模、預測和趨勢分析
  • 醫院和臨床實驗室
  • 學術研究所
  • 生物製藥公司

7. ELISpot 和 Fluorospot 檢測市場（按地區分類）、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 按國家/地區，2018-2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 依國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 依國家/地區，2018 年至 2030 年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018-2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • BD
    • U-CyTech
    • Cellular Technology Limited
    • Mabtech
    • Abcam Limited
    • Autoimmun Diagnostika GmbH
    • Lophius Biosciences GmbH
    • Bio-Connect BV
    • Oxford Immunotec
    • Bio-Techne Corporation
Product Code: GVR-4-68040-349-9

ELISpot And Fluorospot Assay Market Trends:

The global ELISpot and fluorospot assay market size was estimated at USD 311.8 million in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2030. This growth can be attributed to the rising incidences of chronic and infectious diseases, increasing drug discovery activities, rising adoption in research and diagnostics, and expanding pre-clinical and clinically regulated bioanalysis. The ELISpot and fluorospot assays are used to access immune responses, increasing their importance in understanding the effect of various diseases on the immune system, including cancer.

ELISpot and Fluorospot assay are used to detect and characterize naturally occurring tumor-reactive T-cells, which serve as suitable mediators of cancer immunotherapy. Moreover, these assays are also being used for epitope mapping, identification of tumor antigens, and monitor vaccine-induced T and B-cell responses. Moreover, the development of hepatocellular carcinoma (HCC) and cervical cancer is closely linked to high-risk infections with human papillomavirus (HPV) and hepatitis B virus (HBV), respectively. Tumor-specific vaccines are frequently tested in animal models and cell lines; for example, the HPV vaccine was assessed in mice and cell lines using the IFN-Y and IL-2 ELISPOT assay.

Detection of antigen-specific T cell responses via the IFN-Y ELISPOT assay in a patient with metastatic cervical cancer aids researchers in developing new treatment strategies. Researchers are working to halt cancer progression by inducing tumor-specific cytotoxic T lymphocytes (CTLs) through dendritic cells loaded with tumor DNA or tumor homogenate. Another approach involves generating virus-vectored genetic vaccines, such as using an Adenovirus vector encoding tumor antigens. The response of tumor-specific CTLs can be determined by the ELISPOT assay.

The IFN-Y ELISPOT assay is also used to evaluate the immunological efficacy of high-dose IL-2 treatment in patients with metastatic melanoma and renal cell carcinoma. These increasing applications of ELISpot and Fluorospot assays in cancer research are anticipated to drive their demand with increasing cancer incidences. According to National Cancer Institute data, the number of cancer cases per year is anticipated to increase to 29.9 million and cancer-related deaths to reach 15.3 million. This surge in cancer cases is anticipated to drive the market growth over the forecast period.

These assays provide a powerful tool for assessing a potential drug substance's effect on the immune system. ELISpot is emerging as a critical tool in vaccine development for various conditions, such as immunodeficiency syndrome (AIDS), malaria, tuberculosis, cancer, and flu. The ELISpot test is widely utilized in clinical studies to evaluate vaccines. According to the World Health Organization's (WHO) International Clinical Trials Registry Platform (ICTRP) data, 54,952 clinical trials were performed globally in 2022 alone. These increasing clinical trials and drug discovery activities are expected to increase the demand for ELISpot and Fluorospot assay, thereby driving market growth.

Moreover, several market players are increasing their efforts to develop advanced solutions based on ELISpot and Fluorospot assays for various health conditions, which is further driving the market growth. For instance, in November 2023, Revvity announced the launch of its FDA-approved ELISPOT technology-based T-SPOT test in India for latent TB screening. The test uses a standardized sample, which reduces the influence of blood factors that can impact the test performance and normalization for T-cell count.

Global ELISpot And Fluorospot Assay Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ELISpot and fluorospot assay market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Assay Kits
  • Analyzers
  • Ancillary Products
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital and Clinical Labs
  • Academic and Research Institutes
  • Biopharmaceutical Company
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. ELISpot and Fluorospot Assay Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. ELISpot and Fluorospot Assay Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Assay Kits
    • 4.4.1. Assay Kits Market, 2018 - 2030 (USD Million)
  • 4.5. Analyzers
    • 4.5.1. Analyzers Market, 2018 - 2030 (USD Million)
  • 4.6. Ancillary Products
    • 4.6.1. Ancillary Products Market, 2018 - 2030 (USD Million)

Chapter 5. ELISpot and Fluorospot Assay Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Research Applications
    • 5.4.1. Research Applications Market, 2018 - 2030 (USD Million)
  • 5.5. Diagnostics Applications
    • 5.5.1. Diagnostics Applications Market, 2018 - 2030 (USD Million)

Chapter 6. ELISpot and Fluorospot Assay Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital and Clinical Labs
    • 6.4.1. Hospital and Clinical Labs Market, 2018 - 2030 (USD Million)
  • 6.5. Academic and Research Institutes
    • 6.5.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.6. Biopharmaceutical Company
    • 6.6.1. Biopharmaceutical Company Market, 2018 - 2030 (USD Million)

Chapter 7. ELISpot and Fluorospot Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA ELISpot and Fluorospot Assay Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait ELISpot and Fluorospot Assay Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. BD
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. U-CyTech
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Cellular Technology Limited
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Mabtech
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Abcam Limited
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Autoimmun Diagnostika GmbH
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Lophius Biosciences GmbH
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Bio-Connect B.V.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Oxford Immunotec
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Bio-Techne Corporation
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global ELISpot and fluorospot assay market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 12 U.S. ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 15 Canada ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 31 France ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 32 France ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 40 Norway ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 41 Norway ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Denmark ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 44 Denmark ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Sweden ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 47 Sweden ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 53 Japan ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 56 China ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 57 China ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 59 India ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 60 India ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 62 Australia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 64 South Korea ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 65 South Korea ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 66 South Korea ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Thailand ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 68 Thailand ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 69 Thailand ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 72 Latin America ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 75 Brazil ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 78 Argentina ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa ELISpot and fluorospot assay market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 85 South Africa ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait ELISpot and fluorospot assay market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ELISpot and fluorospot assay market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait ELISpot and fluorospot assay market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 ELISpot and fluorospot assay market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 ELISpot and fluorospot assay market dynamics
  • Fig. 13 ELISpot and fluorospot assay market: Porter's five forces analysis
  • Fig. 14 ELISpot and fluorospot assay market: PESTLE analysis
  • Fig. 15 ELISpot and fluorospot assay market: Product segment dashboard
  • Fig. 16 ELISpot and fluorospot assay market: Product market share analysis, 2024 & 2030
  • Fig. 17 Assay kits market, 2018 - 2030 (USD Million)
  • Fig. 18 Analyzers market, 2018 - 2030 (USD Million)
  • Fig. 19 Ancillary products market, 2018 - 2030 (USD Million)
  • Fig. 20 ELISpot and fluorospot assay market: Application segment dashboard
  • Fig. 21 ELISpot and fluorospot assay market: Application market share analysis, 2024 & 2030
  • Fig. 22 Research applications market, 2018 - 2030 (USD Million)
  • Fig. 23 Diagnostics applications market, 2018 - 2030 (USD Million)
  • Fig. 24 ELISpot and fluorospot assay market: End use segment dashboard
  • Fig. 25 ELISpot and fluorospot assay market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospital and clinical labs market, 2018 - 2030 (USD Million)
  • Fig. 27 Academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical company market, 2018 - 2030 (USD Million)
  • Fig. 29 ELISpot and fluorospot assay market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. country dynamics
  • Fig. 34 U.S. ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada country dynamics
  • Fig. 36 Canada ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico country dynamics
  • Fig. 38 Mexico ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 40 UK country dynamics
  • Fig. 41 UK ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany country dynamics
  • Fig. 43 Germany ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 44 France country dynamics
  • Fig. 45 France ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 46 Italy country dynamics
  • Fig. 47 Italy ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain country dynamics
  • Fig. 49 Spain ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway country dynamics
  • Fig. 51 Norway ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden country dynamics
  • Fig. 53 Sweden ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark country dynamics
  • Fig. 55 Denmark ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 57 Japan country dynamics
  • Fig. 58 Japan ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 59 China country dynamics
  • Fig. 60 China ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 61 India country dynamics
  • Fig. 62 India ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia country dynamics
  • Fig. 64 Australia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea country dynamics
  • Fig. 66 South Korea ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 67 Thailand country dynamics
  • Fig. 68 Thailand ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil country dynamics
  • Fig. 71 Brazil ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina country dynamics
  • Fig. 73 Argentina ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 74 MEA ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 75 South Africa country dynamics
  • Fig. 76 South Africa ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 77 Saudi Arabia country dynamics
  • Fig. 78 Saudi Arabia ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 79 UAE country dynamics
  • Fig. 80 UAE ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait country dynamics
  • Fig. 82 Kuwait ELISpot and fluorospot assay market, 2018 - 2030 (USD Million)
  • Fig. 83 Company categorization
  • Fig. 84 Company market position analysis
  • Fig. 85 Strategic framework